An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 - Eli Lilly and Company
business 2026/03/12 08:48:18

An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 - Eli Lilly and Company

Source:Lilly.com
Author:None

The Investor Relations website contains information about Eli Lilly and Company’s business for stockholders, potential investors, and financial analysts.